Dose Response to a Single Intramuscular Injection of Recombinant Adeno-Associated Virus–Erythropoietin in Monkeys
- 15 May 2000
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 90 (2) , 102-108
- https://doi.org/10.1006/jsre.2000.5859
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporationProceedings of the National Academy of Sciences, 1999
- Safe and Effective Regulation of Hematocrit by Gene Gun Administration of an Erythropoietin-Encoding DNA PlasmidHuman Gene Therapy, 1999
- Control of Erythropoietin Secretion by Doxycycline or Mifepristone in Mice Bearing Polymer-Encapsulated Engineered CellsHuman Gene Therapy, 1999
- Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblastsGene Therapy, 1998
- Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primatesGene Therapy, 1998
- Long-Term Erythropoietin Expression in Rodents and Non-Human Primates Following Intramuscular Injection of a Replication-Defective Adenoviral VectorHuman Gene Therapy, 1997
- Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic proteinProceedings of the National Academy of Sciences, 1996
- Gene therapy for long-term expression of erythropoietin in rats.Proceedings of the National Academy of Sciences, 1995
- Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.Proceedings of the National Academy of Sciences, 1992
- ErythropoietinBlood, 1991